203 related articles for article (PubMed ID: 37016804)
1. Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Yeh YM; Lee SY; Kuo HC; Yang CY
J Child Psychol Psychiatry; 2023 Sep; 64(9):1280-1291. PubMed ID: 37016804
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota and plasma cytokine levels in patients with attention-deficit/hyperactivity disorder.
Wang LJ; Li SC; Li SW; Kuo HC; Lee SY; Huang LH; Chin CY; Yang CY
Transl Psychiatry; 2022 Feb; 12(1):76. PubMed ID: 35197458
[TBL] [Abstract][Full Text] [Related]
3. Exploring the gut mycobiome: differential composition and clinical associations in hypertension, chronic kidney disease, and their comorbidity.
Qiu J; Zhao L; Cheng Y; Chen Q; Xu Y; Lu Y; Gao J; Lei W; Yan C; Ling Z; Wu S
Front Immunol; 2023; 14():1317809. PubMed ID: 38162661
[TBL] [Abstract][Full Text] [Related]
4. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
[TBL] [Abstract][Full Text] [Related]
5. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
Yadav M; Ali S; Shrode RL; Shahi SK; Jensen SN; Hoang J; Cassidy S; Olalde H; Guseva N; Paullus M; Cherwin C; Wang K; Cho T; Kamholz J; Mangalam AK
PLoS One; 2022; 17(4):e0264556. PubMed ID: 35472144
[TBL] [Abstract][Full Text] [Related]
7. Host Factors Associated with Gut Mycobiome Structure.
Szóstak N; Handschuh L; Samelak-Czajka A; Tomela K; Schmidt M; Pruss Ł; Milanowska-Zabel K; Kozlowski P; Philips A
mSystems; 2023 Apr; 8(2):e0098622. PubMed ID: 36786595
[TBL] [Abstract][Full Text] [Related]
8. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
9. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
10. Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.
Li J; Chen D; Yu B; He J; Zheng P; Mao X; Yu J; Luo J; Tian G; Huang Z; Luo Y
Microb Ecol; 2018 May; 75(4):821-829. PubMed ID: 29110065
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Microbiome Alterations Following Consumption of BIOHM, a Novel Probiotic.
Ghannoum MA; McCormick TS; Retuerto M; Bebek G; Cousineau S; Hartman L; Barth C; Schrom K
Curr Issues Mol Biol; 2021 Nov; 43(3):2135-2146. PubMed ID: 34940122
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the gut mycobiome with coronary artery disease severity.
An K; Jia Y; Xie B; Gao J; Chen Y; Yuan W; Zhong J; Su P; Liu X
EBioMedicine; 2024 May; 103():105137. PubMed ID: 38703606
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.
Zhang L; Chen C; Chai D; Li C; Qiu Z; Kuang T; Liu L; Deng W; Wang W
J Transl Med; 2023 Feb; 21(1):126. PubMed ID: 36793057
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
Kanj AN; Kottom TJ; Schaefbauer KJ; Choudhury M; Limper AH; Skalski JH
Respir Res; 2023 May; 24(1):144. PubMed ID: 37259076
[TBL] [Abstract][Full Text] [Related]
15. Gut mycobiome dysbiosis contributes to the development of hypertension and its response to immunoglobulin light chains.
Zou Y; Ge A; Lydia B; Huang C; Wang Q; Yu Y
Front Immunol; 2022; 13():1089295. PubMed ID: 36643913
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.
Lang S; Duan Y; Liu J; Torralba MG; Kuelbs C; Ventura-Cots M; Abraldes JG; Bosques-Padilla F; Verna EC; Brown RS; Vargas V; Altamirano J; Caballería J; Shawcross D; Lucey MR; Louvet A; Mathurin P; Garcia-Tsao G; Ho SB; Tu XM; Bataller R; Stärkel P; Fouts DE; Schnabl B
Hepatology; 2020 Feb; 71(2):522-538. PubMed ID: 31228214
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gut mycobiota in first-episode, drug-naïve Chinese patients with schizophrenia: A pilot study.
Zhang X; Pan LY; Zhang Z; Zhou YY; Jiang HY; Ruan B
Behav Brain Res; 2020 Feb; 379():112374. PubMed ID: 31759045
[TBL] [Abstract][Full Text] [Related]
19. Composition of the Gut Microbiota in Attention Deficit Hyperactivity Disorder: A Systematic Review and Meta-Analysis.
Wang N; Gao X; Zhang Z; Yang L
Front Endocrinol (Lausanne); 2022; 13():838941. PubMed ID: 35370947
[TBL] [Abstract][Full Text] [Related]
20. Gut Mycobiome in Patients With Chronic Kidney Disease Was Altered and Associated With Immunological Profiles.
Hu J; Wei S; Gu Y; Wang Y; Feng Y; Sheng J; Hu L; Gu C; Jiang P; Tian Y; Guo W; Lv L; Liu F; Zou Y; Yan F; Feng N
Front Immunol; 2022; 13():843695. PubMed ID: 35784313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
